Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5597130 | The Annals of Thoracic Surgery | 2016 | 7 Pages |
Abstract
For degenerated bioprosthetic aortic valves, TViV has similar operative mortality, strokes rates, and survival as SAVR in this high-risk cohort. Therefore, TViV is a viable alternative to SAVR, although studies using registry data are needed to establish noninferiority.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Julius I. MD, Maroun MD, Morgan T. MD, Siobhan BS, Jochen D. MD, MMS, Prem S. MD, Lawrence H. MD, Pinak MD, Tsuyoshi MD,